Review article: Associations between Helicobacter pylori and obesity--an ecological study.

PubWeight™: 2.69‹?› | Rank: Top 1%

🔗 View Article (PMID 24832176)

Published in Aliment Pharmacol Ther on May 15, 2014

Authors

N Lender1, N J Talley, P Enck, S Haag, S Zipfel, M Morrison, G J Holtmann

Author Affiliations

1: Department of Gastroenterology & Hepatology, Princess Alexandra Hospital, Woolloongabba, Qld, Australia; Faculty of Medicine and Biomedicine & Faculty of Health and Behavioural Sciences, University of Queensland, St Lucia, Qld, Australia.

Articles citing this

Weight gain after fecal microbiota transplantation. Open Forum Infect Dis (2015) 2.05

Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits. Gastroenterology (2015) 1.85

ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. Am J Gastroenterol (2017) 1.11

Letter: inverse correlation between Helicobacter pylori and obesity - a conclusion too early? Aliment Pharmacol Ther (2014) 1.06

Helicobacter pylori Eradication Causes Perturbation of the Human Gut Microbiome in Young Adults. PLoS One (2016) 0.88

Helicobacter pylori infection can affect energy modulating hormones and body weight in germ free mice. Sci Rep (2015) 0.85

No increase in gastric acid secretion in healthy Japanese over the past two decades. J Gastroenterol (2014) 0.79

Modeling the Regulatory Mechanisms by Which NLRX1 Modulates Innate Immune Responses to Helicobacter pylori Infection. PLoS One (2015) 0.79

Obesity and the Incidence of Upper Gastrointestinal Cancers: An Ecological Approach to Examine Differences across Age and Sex. Cancer Epidemiol Biomarkers Prev (2015) 0.79

Systems-wide analyses of mucosal immune responses to Helicobacter pylori at the interface between pathogenicity and symbiosis. Gut Microbes (2016) 0.78

The Clinical Evidence Linking Helicobacter pylori to Gastric Cancer. Cell Mol Gastroenterol Hepatol (2016) 0.76

Towards a healthy stomach? Helicobacter pylori prevalence has dramatically decreased over 23 years in adults in a Swedish community. United European Gastroenterol J (2015) 0.75

Changes in plasma ghrelin and leptin levels in patients with peptic ulcer and gastritis following eradication of Helicobacter pylori infection. BMC Gastroenterol (2016) 0.75

Helicobacter pylori is associated with dyslipidemia but not with other risk factors of cardiovascular disease. Sci Rep (2016) 0.75

Letter: inverse correlation between Helicobacter pylori and obesity - a conclusion too early? Authors' reply. Aliment Pharmacol Ther (2014) 0.75

Elderly women who received Helicobacter pylori-eradicating therapy have reduced risk of low skeletal muscle mass. Clin Interv Aging (2015) 0.75

Predicting the Future Burden of Esophageal Cancer by Histological Subtype: International Trends in Incidence up to 2030. Am J Gastroenterol (2017) 0.75

Articles by these authors

Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51

U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci (1993) 7.98

Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N Engl J Med (1998) 4.66

Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. JAMA (1998) 4.62

Exposed protein on the intact human erythrocyte. Biochemistry (1971) 4.56

The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut (2008) 3.92

Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut (2008) 3.81

Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med (2001) 3.68

Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex. Genes Dev (2001) 3.67

The arrangement of proteins in the human erythrocyte membrane. Biochem Biophys Res Commun (1970) 3.54

A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc (1994) 3.14

Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol (1999) 3.01

Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology (1996) 3.00

The brain--gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut (2012) 2.96

Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol (2000) 2.89

Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis. Gut (2008) 2.82

Sexual and physical abuse and gastrointestinal illness. Review and recommendations. Ann Intern Med (1995) 2.78

Risk factors associated with symptoms of gastroesophageal reflux. Am J Med (1999) 2.75

Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology (1990) 2.75

The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor. Aliment Pharmacol Ther (2013) 2.73

Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol (1996) 2.73

The irritable bowel syndrome: long-term prognosis and the physician-patient interaction. Ann Intern Med (1995) 2.73

Prevalence of Helicobacter pylori in specific forms of gastritis. Further evidence supporting a pathogenic role for H. pylori in chronic nonspecific gastritis. Dig Dis Sci (1991) 2.67

Risk of developing colorectal cancer and benign colorectal neoplasm in patients with chronic constipation. Aliment Pharmacol Ther (2014) 2.67

Menetrier's disease: a form of hypertrophic gastropathy or gastritis? Gastroenterology (1993) 2.52

Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol (1998) 2.38

Functional dyspepsia: the economic impact to patients. Aliment Pharmacol Ther (2013) 2.36

Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther (2004) 2.35

Cost-effectiveness of cimetidine maintenance therapy in chronic gastric and duodenal ulcer. Gastroenterology (1990) 2.32

Oesophageal narrowing is common and frequently under-appreciated at endoscopy in patients with oesophageal eosinophilia. Aliment Pharmacol Ther (2014) 2.30

Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther (2003) 2.28

A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol (2000) 2.27

Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl (1998) 2.26

Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol (2001) 2.23

Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology (2001) 2.22

Use of lactoperoxidase catalyzed iodination in immunochemical studies. Immunochemistry (1971) 2.19

Long-term outcome of anorexia nervosa in a prospective 21-year follow-up study. Psychol Med (2001) 2.17

Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population-based study. Aliment Pharmacol Ther (2015) 2.17

Peroxidase-catalyzed halogenation. Annu Rev Biochem (1976) 2.16

Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol (2001) 2.12

The overlap of atopy and functional gastrointestinal disorders among 23,471 patients in primary care. Aliment Pharmacol Ther (2014) 2.05

Evaluation of the Abbott LCx ligase chain reaction assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine and genital swab specimens from a sexually transmitted disease clinic population. J Clin Microbiol (1998) 2.04

The association between non-ulcer dyspepsia and other gastrointestinal disorders. Scand J Gastroenterol (1985) 2.01

Affective disturbances modulate the neural processing of visceral pain stimuli in irritable bowel syndrome: an fMRI study. Gut (2009) 1.97

Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol (1998) 1.96

The determination of the exposed proteins on membranes by the use of lactoperoxidase. Methods Enzymol (1974) 1.94

Adaptation to herbivory by the Tammar wallaby includes bacterial and glycoside hydrolase profiles different from other herbivores. Proc Natl Acad Sci U S A (2010) 1.89

Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am J Gastroenterol (2001) 1.85

Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol (2001) 1.84

Non-cardiac chest pain: prevalence, risk factors, impact and consulting--a population-based study. Aliment Pharmacol Ther (2003) 1.84

Mortality rates in patients with Barrett's oesophagus. Aliment Pharmacol Ther (2007) 1.81

Properties of mouse globin messenger ribonucleic acid and its preparation in milligram quantities. Biochemistry (1971) 1.79

Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia. Gut (2004) 1.76

Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res (2004) 1.76

Short segment Barrett's oesophagus: prevalence, diagnosis and associations. Gut (1997) 1.75

Lactoperoxidase-catalyzed iodination as a tool for investigation of proteins. Methods Enzymol (1980) 1.75

The effects of lottery incentive and length of questionnaire on health survey response rates: a randomized study. J Clin Epidemiol (1999) 1.73

Long-term prognosis in anorexia nervosa: lessons from a 21-year follow-up study. Lancet (2000) 1.73

The visualization of human erythrocyte membrane proteins and glycoproteins in SDS polyacrylamide gels employing a single staining procedure. Anal Biochem (1976) 1.72

Highlighting new phylogenetic specificities of Crohn's disease microbiota. Inflamm Bowel Dis (2010) 1.70

Serotonin type-4 receptors modulate the sensitivity of intramural mechanoreceptive afferents of the cat rectum. Neurogastroenterol Motil (2002) 1.70

Differences in gastric mechanosensory function after repeated ramp distensions in non-consulters with dyspepsia and healthy controls. Gut (2000) 1.70

Association of anxiety, neuroticism, and depression with dyspepsia of unknown cause. A case-control study. Gastroenterology (1986) 1.69

Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture. Aliment Pharmacol Ther (2011) 1.68

Development and validation of the Diabetes Bowel Symptom Questionnaire. Aliment Pharmacol Ther (2003) 1.68

Minimum standards of anorectal manometry. Neurogastroenterol Motil (2002) 1.66

A biomarker panel and psychological morbidity differentiates the irritable bowel syndrome from health and provides novel pathophysiological leads. Aliment Pharmacol Ther (2014) 1.64

Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc (2000) 1.64

The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole. Aliment Pharmacol Ther (2004) 1.64

Non-cardiac chest pain: squeezing the life out of the Australian healthcare system? Med J Aust (2000) 1.63

Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut (2004) 1.60

Eosinophil infiltration and degranulation in normal human tissue. Anat Rec (1998) 1.59

Gastroscopy is incomplete without biopsy: clinical relevance of distinguishing gastropathy from gastritis. Gastroenterology (1995) 1.59

HCP-1, a protein involved in chromosome segregation, is localized to the centromere of mitotic chromosomes in Caenorhabditis elegans. J Cell Biol (1999) 1.59

Does Helicobacter pylori colonize the gastric mucosa of Meckel's diverticulum? Mayo Clin Proc (1990) 1.59

Cerebral responses evoked by electrical stimulation of rectosigmoid in normal subjects. Dig Dis Sci (1989) 1.58

Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil (2005) 1.56

ABC of the upper gastrointestingal tract: Indigestion: When is it functional? BMJ (2001) 1.56

Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study. Mayo Clin Proc (1992) 1.53

Discriminant value of dyspeptic symptoms: a study of the clinical presentation of 221 patients with dyspepsia of unknown cause, peptic ulceration, and cholelithiasis. Gut (1987) 1.52

A vegan or vegetarian diet substantially alters the human colonic faecal microbiota. Eur J Clin Nutr (2011) 1.52

Is there a benefit from intensified medical and psychological interventions in patients with functional dyspepsia not responding to conventional therapy? Aliment Pharmacol Ther (2007) 1.51

Visceral perception in functional gastro-intestinal disorders: disease marker or epiphenomenon? Dig Dis (1997) 1.51

Factors associated with consulting medical or non-medical practitioners for dyspepsia: an australian population-based study. Aliment Pharmacol Ther (2000) 1.51

Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population--the Kalixanda study. Aliment Pharmacol Ther (2006) 1.49

Valid symptom reporting at upper endoscopy in a random sample of the Swedish adult general population: the Kalixanda study. Scand J Gastroenterol (2004) 1.49

Oesophageal eosinophilic infiltration in patients with noncardiac chest pain. Aliment Pharmacol Ther (2011) 1.49

Antistreptococcal activity of lactoperoxidase. J Bacteriol (1969) 1.49

Natural acquisition and spontaneous elimination of Helicobacter pylori infection: clinical implications. Am J Gastroenterol (1997) 1.48

Short-term results of laryngeal framework surgery--thyroplasty type 1: A pilot study. J Otolaryngol (1995) 1.48

Catalysis of iodination by lactoperoxidase. Biochemistry (1970) 1.48

Management of gastro-oesophageal reflux disease in general practice. BMJ (2001) 1.48

Colonic tone and motility in patients with irritable bowel syndrome. Mayo Clin Proc (1992) 1.46

Anal endosonography and manometry: comparison in patients with defecation problems. Dis Colon Rectum (1997) 1.46

Abuse and functional gastrointestinal disorders: what is the link and should we care? Gastroenterology (1996) 1.46

Dysphagia: epidemiology, risk factors and impact on quality of life--a population-based study. Aliment Pharmacol Ther (2008) 1.46

The reaction of benzoquinone with amines and proteins. Arch Biochem Biophys (1969) 1.46

[Irritable bowel syndrome: German consensus guidelines on definition, pathophysiology and management]. Z Gastroenterol (2011) 1.46

Irritable bowel syndrome: novel views on the epidemiology and potential risk factors. Dig Liver Dis (2009) 1.45